A new drug appears to help people who suffer from rheumatoid arthritis, but eventually stop benefitting from the use of the current top treatment: injectable, bioengineered proteins that interfere with the action of a powerful inflammatory substance.
Stanford scientists found that a discarded drug helps human cells in a lab dish fight off two different viruses. Based on what they learned about how the drug works, it might also help fight the viruses that cause Ebola, dengue and Zika, among others.
Inside Stanford Medicineis a twice-monthly newspaper that reports on the accomplishments and activities of the faculty, staff and students in the Stanford Medicine community. To suggest a story or to get more information, contact editor John Sanford at (650) 723-8309 or email@example.com.
You're receiving this newsletter because you registered with us.
Not interested anymore? Unsubscribe here.